Livzon Pharmaceutical Group's total assets for Q3 2025 were ¥26.82B, an increase of 10.95% from the previous quarter. LVZPF total liabilities were ¥10.02B for the fiscal quarter, a 8.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.